Evidence map›Paper›PMID 23844360›Full record

ReviewBioMed research international2013

Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.

P Alvarez, E Carrillo, C Vélez, F Hita-Contreras, A Martínez-Amat, F Rodríguez-Serrano, H Boulaiz, R Ortiz, C Melguizo, J Prados and 1 more

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01978821 (Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01978821 phase1withdrawnnot on this map

Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy

TypeinterventionalSponsorNeurogen Brain and Spine InstituteRan2010 to 2013Enrolled0ConditionsCerebral PalsyArmsAutologous bone marrow mononuclear cell transplantation
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vascular precursor cells in tissue injury repair.Translational research : the journal of laboratory and clinical medicine · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.Journal of the American Society of Nephrology : JASN · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

P AlvarezInstitute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, 18100 Granada, Spain.
E Carrillo
C Vélez
F Hita-Contreras
A Martínez-Amat
F Rodríguez-Serrano
H Boulaiz
R Ortiz
C Melguizo
J Prados
A Aránega
Universidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of hematopoietic stem cell release, migration, and homing from the bone marrow (BM) and of the mobilization pathway involves a complex interaction among adhesion molecules, cytokines, proteolytic enzymes, stromal cells, and hematopoietic cells. The identification of new mechanisms that regulate the trafficking of hematopoietic stem/progenitor cells (HSPCs) cells has important implications, not only for hematopoietic transplantation but also for cell therapies in regenerative medicine for patients with acute myocardial infarction, spinal cord injury, and stroke, among others. This paper reviews the regulation mechanisms underlying the homing and mobilization of BM hematopoietic stem/progenitor cells, investigating the following issues: (a) the role of different factors, such as stromal cell derived factor-1 (SDF-1), granulocyte colony-stimulating factor (G-CSF), and vascular cell adhesion molecule-1 (VCAM-1), among other ligands; (b) the stem cell count in peripheral blood and BM and influential factors; (c) the therapeutic utilization of this phenomenon in lesions in different tissues, examining the agents involved in HSPCs mobilization, such as the different forms of G-CSF, plerixafor, and natalizumab; and (d) the effects of this mobilization on BM-derived stem/progenitor cells in clinical trials of patients with different diseases.

Indexed as

Cell MovementHematopoietic Stem Cell MobilizationAnimalsBone MarrowClinical Trials as TopicHematopoietic Stem CellsHumansStem Cell Transplantation

Identifiers

PMID23844360
PMCPMC3703413
OpenAlexW2130304173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.